FDA Inspection 1295446 — AstraZeneca AB
The FDA completed an inspection of AstraZeneca AB on Nov 13, 2025 in Sodertalje. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 13, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Sodertalje (Sweden)